IL7R and acute lymphoblastic leukemia: These findings indicate that the cell growth-promoting effects of the NOTCH1 oncogenic program are enhanced by means of IL7R gene induction and activation of IL-7R signaling, pointing to IL-7R downstream effectors as promising molecular targets for therapeutic intervention in T-ALL.